chr10-98427202-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000195.5(HPS1):​c.987+13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0179 in 1,550,062 control chromosomes in the GnomAD database, including 1,043 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 363 hom., cov: 33)
Exomes 𝑓: 0.015 ( 680 hom. )

Consequence

HPS1
NM_000195.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.962

Publications

4 publications found
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
HPS1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 10-98427202-A-G is Benign according to our data. Variant chr10-98427202-A-G is described in ClinVar as Benign. ClinVar VariationId is 255506.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS1NM_000195.5 linkc.987+13T>C intron_variant Intron 11 of 19 ENST00000361490.9 NP_000186.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS1ENST00000361490.9 linkc.987+13T>C intron_variant Intron 11 of 19 1 NM_000195.5 ENSP00000355310.4 Q92902-1
ENSG00000289758ENST00000699159.1 linkn.*346+13T>C intron_variant Intron 10 of 23 ENSP00000514167.1 A0A8V8TP71

Frequencies

GnomAD3 genomes
AF:
0.0447
AC:
6801
AN:
152218
Hom.:
362
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0226
Gnomad ASJ
AF:
0.00864
Gnomad EAS
AF:
0.0746
Gnomad SAS
AF:
0.0856
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00708
Gnomad OTH
AF:
0.0335
GnomAD2 exomes
AF:
0.0283
AC:
4416
AN:
156290
AF XY:
0.0296
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.00987
Gnomad ASJ exome
AF:
0.00720
Gnomad EAS exome
AF:
0.0801
Gnomad FIN exome
AF:
0.000327
Gnomad NFE exome
AF:
0.00659
Gnomad OTH exome
AF:
0.0178
GnomAD4 exome
AF:
0.0150
AC:
20999
AN:
1397726
Hom.:
680
Cov.:
30
AF XY:
0.0162
AC XY:
11188
AN XY:
689522
show subpopulations
African (AFR)
AF:
0.128
AC:
4054
AN:
31550
American (AMR)
AF:
0.0124
AC:
441
AN:
35694
Ashkenazi Jewish (ASJ)
AF:
0.00708
AC:
178
AN:
25152
East Asian (EAS)
AF:
0.0562
AC:
2016
AN:
35842
South Asian (SAS)
AF:
0.0680
AC:
5382
AN:
79162
European-Finnish (FIN)
AF:
0.000937
AC:
46
AN:
49084
Middle Eastern (MID)
AF:
0.0162
AC:
92
AN:
5688
European-Non Finnish (NFE)
AF:
0.00677
AC:
7299
AN:
1077592
Other (OTH)
AF:
0.0257
AC:
1491
AN:
57962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
890
1780
2670
3560
4450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
416
832
1248
1664
2080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0448
AC:
6822
AN:
152336
Hom.:
363
Cov.:
33
AF XY:
0.0443
AC XY:
3300
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.122
AC:
5079
AN:
41570
American (AMR)
AF:
0.0225
AC:
345
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00864
AC:
30
AN:
3472
East Asian (EAS)
AF:
0.0745
AC:
386
AN:
5178
South Asian (SAS)
AF:
0.0854
AC:
413
AN:
4834
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10630
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00709
AC:
482
AN:
68028
Other (OTH)
AF:
0.0350
AC:
74
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
327
654
981
1308
1635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0214
Hom.:
28
Bravo
AF:
0.0487
Asia WGS
AF:
0.0930
AC:
322
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

987+13T>C in intron 11 of HPS1: This variant is not expected to have clinical si gnificance because it is not located within the conserved splice consensus seque nce. It has been identified in 10.8% (448/4134) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.was hington.edu/EVS; dbSNP rs12571249). -

Hermansky-Pudlak syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.015
DANN
Benign
0.22
PhyloP100
-0.96
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12571249; hg19: chr10-100186959; API